Methylation levels of sodium-iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression

Endocrine

Volumn 43, Issue 1, 2013, Pages 225-229

  Galrao A L ^a   Sodre A K ^a   Camargo, R Y ^a   Friguglietti, C U ^b   Kulcsar, M A ^a   Lima, E U ^a   Medeiros Neto, G ^a   Rubio, I G S ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL SANTA CATARINA   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

DNA methylation; Iodine; NIS symporter; Thyroid cancer; Thyroid nodule

Indexed keywords

B RAF KINASE; DNA; MESSENGER RNA; SODIUM IODIDE SYMPORTER;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BRAF GENE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA METHYLATION; FEMALE; GENE; GENE LOCATION; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NIS GENE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; THYROID CANCER; THYROID TUMOR;

EID: 84872350060     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9779-8     Document Type: Article

References (16)

1. N. Carrasco, Iodide transport in the thyroid gland. Biochim. Biophys. Acta 1154(1), 65-82 (1993)
2. O. Dohan, A. De la Vieja, V. Paroder, C. Riedel, M. Artani, M. Reed et al., The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr. Rev. 24(1), 48-77 (2003)
3. M. Rodriguez-Paredes, M. Esteller, Cancer epigenetics reaches mainstream oncology (Review). Nat. Med. 17(3), 330-339 (2011)
4. Xing M. Gene methylation in thyroid tumorigenesis. Endocrinology. 148(3), 948-953 (2007) (Research Support, Non-U.S. Gov't Review)
5. A.K. Sodre, I.G. Rubio, A.L. Galrao, M. Knobel, E.K. Tomimori, V.A. Alves et al., Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining. J. Clin. Endocrinol. Metab. 93(10), 4141-4145 (2008)
6. S. Trouttet-Masson, S. Selmi-Ruby, F. Bernier-Valentin, V. Porra, N. Berger-Dutrieux, M. Decaussin et al., Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors. Am. J. Pathol. 165(1), 25-34 (2004)
7. +/I-symporter gene methylation status. J. Clin. Endocrinol. Metab. 84(7), 2449-2457 (1999)
8. S. Neumann, K. Schuchardt, A. Reske, P. Emmrich, R. Paschke, Lack of correlation for sodium iodide symporter mRNA and protein expression and analysis of sodium iodide symporter promoter methylation in benign cold thyroid nodules. Thyroid 14(2), 99-111 (2004)
9. J.K. Stephen, D. Chitale, V. Narra, K.M. Chen, R. Sawhney, M.J. Worsham, DNA methylation in thyroid tumorigenesis. Cancers (Basel) 3(2), 1732-1743 (2011)
10. J.A. Smith, C.Y. Fan, C. Zou, D. Bodenner, M.S. Kokoska, Methylation status of genes in papillary thyroid carcinoma. Arch. Otolaryngol. Head Neck Surg. 133(10), 1006-1011 (2007)
11. K. Woodson, R. Hayes, L. Wideroff, L. Villaruz, J. Tangrea, Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites. Prostate 55(3), 199-205 (2003)
12. G. Oler, J.M. Cerutti, High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes. Cancer 115(5), 972-980 (2009)
13. G. Riesco-Eizaguirre, I. Rodriguez, A. De la Vieja, E. Costamagna, N. Carrasco, M. Nistal et al., The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res. 69(21), 8317-8325 (2009)
14. P.A. Jones, Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13(7), 484-492 (2012)
15. M.J. Provenzano, M.P. Fitzgerald, K. Krager, F.E. Domann, Increased iodine uptake in thyroid carcinoma after treatment with sodium butyrate and decitabine (5-Aza-dC). Otolaryngol. Head Neck Surg. 137(5), 722-728 (2007)
16. Russo D, Damante G, Puxeddu E, Durante C, Filetti S. Epigenetics of thyroid cancer and novel therapeutic targets. J Mol Endocrinol. 46(3), R73-81 (2011) (Research Support, Non-U.S. Gov't Review)